An observational study in Endometriosis, sponsored by University of Cagliari. Completed. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-11-06.
Sponsored by University of Cagliari · Observational
Endometriosis is one of the most common benign gynecological, affecting about 10% of premenopausal women. The pathophysiology of this disease is still not completely clear. Despite its prevalence, there is no blood test available for the diagnosis of endometriosis and the average delay time to diagnosis is 9.4 years.
Metabolomics is a scientific discipline that studies changes in metabolites related to the pathophysiology of the disease.
Aim of the study is to identify an alteration in the expression of the metabolites in women with endometriosis
901 studies on the registry are indexed under Endometriosis; 259 are open to participants now.
This study's enrollment of 54 is below the median of 128 across 344 observational studies indexed under Endometriosis.
Browse Endometriosis studies →University of Cagliari is the lead sponsor of 82 studies on the registry; 17 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.
Counted across the registry records on this site, refreshed daily.
women of childbearing age , patients of the University Hospital , suffering from benign gynecological disease
Exclusion Criteria:
Patients will undergo laparoscopic surgery in order to treat endometriosis. Biopsies will be performed for histological confirmation of the disease. Samples of urine and blood, with the purpose to study metabolitis, will be collected before surgery.
Procedure: laparoscopic surgery, obtainment of biological samples
Patients will undergo laparoscopic surgery in order to treat benign gynecological diseases. Biopsies will be performed for histological confirmation of the disease. Samples of urine and blood,with the purpose to study metabolitis, will be collected before surgery.
Procedure: laparoscopic surgery, obtainment of biological samples
Plasma and urine concentration of metabolites
Time frame: At least one month after discontinuation of hormonal therapies , before laparoscopic surgery
No study locations are listed for this record.
This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Cagliari